Role of Aneuploid Circulating Tumor Cells and CD31+ Circulating Tumor Endothelial Cells in Predicting and Monitoring Anti-angiogenic Therapy Efficacy in Advanced NSCLC

By
Justin.choi
-
0
85
Co-detection and comprehensive phenotypic and karyotypic molecular characterization of aneuploid circulating tumor cells and circulating tumor endothelial cells were conducted on non-small cell lung cancer patients receiving bevacizumab plus chemotherapy.
[Molecular Oncology]
Zhang, T., Zhang, L., Gao, Y., Wang, Y., Liu, Y., Zhang, H., Wang, Q., Hu, F., Li, J., Tan, J., Wang, D. D., Gires, O., Lin, P. P., & Li, B. (n.d.). Role of aneuploid circulating tumor cells and CD31+ circulating tumor endothelial cells in predicting and monitoring anti-angiogenic therapy efficacy in advanced NSCLC. Molecular Oncology, n/a(n/a). https://doi.org/10.1002/1878-0261.13092 Cite
Abstract